To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
819 Newest Publications of de Gruyterrss
|You can refine your search further. Select from the filter options on the left to narrow down your results.|
19-Mar-2010 | Nuria Estañ-Capell; Carmen Quiñones-Torrelo; Jorge Sánchez-Morillo; Luis Estañ-Jago, Clinical Chemistry , 2010
Abstract Background: Prediction of the duration of motor block after injection of a local anesthetic into cerebrospinal fluid (CSF) would be a very useful tool in clinical practice. However, previous attempts have not shown conclusive results. In this work, glycorrhachia is demonstrated to be an ...
19-Mar-2010 | Cinzia Magagnotti; Isabella Fermo; Rose Mary Carletti; Maurizio Ferrari; Angela Bachi, Clinical Chemistry , 2010
Abstract Background: Urine, being an ultrafiltrate of plasma, is a rich source for biomarker discovery. Since potential new disease markers are often present in low concentrations, a prefractionation/enrichment step could be useful in the discovery process. To enhance the detection of ...
19-Mar-2010 | Thomas Mueller; Benjamin Dieplinger; Thomas Forstner; Werner Poelz; Meinhard Haltmayer, Clinical Chemistry , 2010
Abstract Background: Pregnancy-associated plasma protein-A (PAPP-A) has been associated with peripheral artery disease (PAD). The aim of this study was to evaluate the utility of PAPP-A as a marker for long-term mortality in patients with atherosclerotic PAD. Methods: PAPP-A serum concentrations ...
19-Mar-2010 | Semon Wu; Lung-An Hsu; Ming-Sheng Teng; Jeng Feng Lin; Hsien-Hsun Chang; Pi-Yueh Chang; Chiao-Feng Hu; Yu-Lin Ko, Clinical Chemistry , 2010
Abstract Background: Circulating concentrations of matrix metalloproteinase 9 (MMP-9) are associated with cardiovascular disease mortality in patients with coronary artery disease. We investigated the determinants of MMP-9 concentrations by analyzing MMP-9 genotypes and risk factors for ...
19-Mar-2010 | Weihua Song; Hui Yu; Jingzhou Chen; Kai Sun; Rutai Hui, Clinical Chemistry , 2010
Abstract Background: C-reactive protein (CRP) has been shown to contribute to the risk of cardiovascular disease. Several single nucleotide polymorphisms (SNPs) at the CRP locus have been found to be associated with CRP concentrations. We hypothesized that genetic variants associated with high ...
19-Mar-2010 | Peter Alter; Heinz Rupp; Marga B. Rominger; Jens H. Figiel; Harald Renz; Klaus J. Klose; Bernhard Maisch, Clinical Chemistry , 2010
Abstract Background: Hyperhomocysteinemia is a risk factor for ischemic heart disease. Several other mechanisms apply also to dilative types of heart failure of various, non-ischemic etiologies. We hypothesized that hyperhomocysteinemia is associated with left ventricular (LV) dilatation and ...
19-Mar-2010 | Chiara Caselli; Ombretta Melaiu; Maristella Maltinti; Silvia Del Ry; Manuela Cabiati; Tommaso Prescimone; Dani ..., Clinical Chemistry , 2010
Abstract Background: Adiponectin, present in different multimeric forms in circulation, is increasingly used in clinical settings as a cardiometabolic marker. The development of several commercially available enzyme-linked immunosorbent assays (ELISA) has allowed for the widespread measurement of ...
19-Mar-2010 | Ana Lígia Bender; Inês Guimaraes da Silveira; Carlos Alberto von Mühlen; Henrique Luiz Staub, Clinical Chemistry , 2010
Clinical Chemistry and Laboratory Medicine, Volume 48, Issue 4, Page 569-570, April 2010.
19-Mar-2010 | Yusheng Zhu; Laurie M. Williams; Beverly D. Horne, Clinical Chemistry , 2010
Clinical Chemistry and Laboratory Medicine, Volume 48, Issue 4, Page 571-572, April 2010.